Lib Therapeutics INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCincinnati, OH
SAM.gov UEIGXLUKVAN7WC8
LIB Therapeutics is a biopharmaceutical company developing lerodalcibep, a PCSK9 inhibitor administered as a once-monthly subcutaneous injection for lowering LDL-C levels. The company serves patients with cardiovascular disease, familial hypercholesterolemia, and atherosclerotic cardiovascular disease.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Lib Therapeutics INC | Cincinnati | OH | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.